SIA "EZERES DOKTORĀTS"Active

48503006616Limited liability companyFounded 1999

Key figures

146 520 €-7,7%
Revenue 2025
+8,3%
Average annual growth 2010–2025
050 k100 k150 k200 k’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
050 k100 k150 k’10’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

Paid out in dividends approximately 4000 € (9% of equity at the end of the previous year).

Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).

History
2025 ~4000 €
2024 ~1999 €
20230 €
20220 €
202116 335 €
2020 ~10 999 €
20190 €
2018 ~5619 €
2017 ~7334 €
2016 ~12 182 €
2015 ~13 270 €
2014 ~2933 €
2013 ~4075 €
2012 ~3448 €
2011 ~5000 €
Summary of financial statements2010–2025
2010201120122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets19 42514 2385225522616 82515 93116 01413 45017 66821 02120 04428 79032 12629 94844 54341 549
Total non-current assets2962245996167645816531 19424 25418 31513 90725 50523 51655 07042 03942 03917 83460 928
Total assets22 38716 69714 84112 87124 99047 12540 26831 76531 57546 52643 56083 86074 16571 98762 377102 477
Balance sheet — liabilities and equity
Current liabilities5173521055205286849514 75217 27310 48911 05419 81217 00913 22118 892500016 02212 614
Non-current liabilities003246180637917 34512 81512 81185830028 52713 82221 583119429 706
Total liabilities5173521087667092887432 09730 08823 30019 63719 81217 00941 74832 71426 58317 21642 320
Share capital————————————————
Retained earnings of previous periods————————————————
Profit for the year836385-1964377913 27012 18273345619909214 77610 83631 897-6613959175618 996
Total equity16 40211 4876075577916 11615 02810 180846511 93826 71426 55142 11241 45145 40445 16160 157
Income statement
Sales revenue44 12745 69048 06846 30778 09577 71174 14475 50589 366102 542111 403188 002186 873118 849158 686146 520
Operating profit10 046153-1714398113 45112 25675415769909214 77610 83636 083-6363984225620 320
Profit before income tax975685-1964377913 27012 18273345619909214 77610 83636 083-6363984225619 996
Profit for the reporting year836385-1964377913 27012 18273345619909214 77610 83631 897-6613959175618 996
Labour costs————————————————
Depreciation of non-current assets————————————————
Other indicators
Employees4555555555666666
Calculated dividend—500034484075293313 27012 18273345619010 99916 3350019994000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a node to see its other connections.

100%SIA "EZERES DOKTORĀTS"1Berga Valda
CompanyPersonShareholderOther roleAdditional link

Related companies

Shared members or board members

Summary: SIA "EZERES DOKTORĀTS"

Overview

SIA "EZERES DOKTORĀTS" (reg. no. 48503006616) is a limited liability company. The company was registered in 1999 and has been in the register for 27 years. Registered address: Saldus nov., Ezeres pag., Ezere, Centra iela 2A - 1.

Financial results

Revenue in 2025 was 146 520 €, down 7,7% on the previous year (158 686 €). From 2010 to 2025, revenue grew by an average of 8,3% per year. Net profit for 2025 was 18 996 € (13,0% of revenue). The company was profitable in 14 of the 16 published years. In 2025 the company had 6 employees. Revenue per employee was 24 420 €. At the end of 2025, total assets were 102 477 € and equity 60 157 € (58,7% of assets).

Management and owners

The company has one board member. The sole owner of the company is a private individual.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.